PL1948205T3 - Sposób regulacji metabolicznej i wysokiego stopnia oczyszczania z substancji rozpuszczonych oraz roztwory do stosowania - Google Patents
Sposób regulacji metabolicznej i wysokiego stopnia oczyszczania z substancji rozpuszczonych oraz roztwory do stosowaniaInfo
- Publication number
- PL1948205T3 PL1948205T3 PL06837587T PL06837587T PL1948205T3 PL 1948205 T3 PL1948205 T3 PL 1948205T3 PL 06837587 T PL06837587 T PL 06837587T PL 06837587 T PL06837587 T PL 06837587T PL 1948205 T3 PL1948205 T3 PL 1948205T3
- Authority
- PL
- Poland
- Prior art keywords
- solutions
- metabolic control
- high solute
- solute clearance
- clearance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/273,290 US7884132B2 (en) | 2005-11-14 | 2005-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
EP06837587.2A EP1948205B1 (en) | 2005-11-14 | 2006-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
PCT/US2006/044219 WO2007059145A2 (en) | 2005-11-14 | 2006-11-14 | Process for metabolic control and high solute clearance and solutions for use therein |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1948205T3 true PL1948205T3 (pl) | 2015-12-31 |
Family
ID=38041129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06837587T PL1948205T3 (pl) | 2005-11-14 | 2006-11-14 | Sposób regulacji metabolicznej i wysokiego stopnia oczyszczania z substancji rozpuszczonych oraz roztwory do stosowania |
Country Status (10)
Country | Link |
---|---|
US (2) | US7884132B2 (pl) |
EP (2) | EP3061456B1 (pl) |
JP (1) | JP2009523117A (pl) |
AU (1) | AU2006315455B2 (pl) |
CA (1) | CA2632157C (pl) |
DK (2) | DK3061456T3 (pl) |
ES (2) | ES2832023T3 (pl) |
PL (1) | PL1948205T3 (pl) |
PT (2) | PT3061456T (pl) |
WO (1) | WO2007059145A2 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8133194B2 (en) * | 2006-02-22 | 2012-03-13 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
CA2643140C (en) * | 2006-02-22 | 2014-12-09 | Henry Ford Health System | System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits |
US9603989B2 (en) * | 2010-08-24 | 2017-03-28 | Fenwal, Inc. | Methods for anticoagulating blood |
WO2014177630A1 (en) | 2013-04-30 | 2014-11-06 | Gambro Lundia Ab | A multipart fluid system and a system for citrate anticoagualation in an extracorporeal blood circuit |
AU2014261402B2 (en) | 2013-04-30 | 2018-10-04 | Gambro Lundia Ab | An anticoagulation fluid comprising citrate and phosphate |
WO2017045088A1 (zh) * | 2015-09-15 | 2017-03-23 | 薛迎风 | 全自动枸橼酸局部抗凝机 |
CN115990296A (zh) | 2017-09-22 | 2023-04-21 | 贝克顿·迪金森公司 | 用作导管封管液的4%柠檬酸三钠溶液 |
US20220072211A1 (en) * | 2018-12-20 | 2022-03-10 | University Of Maryland, Baltimore | Hemofiltration device, system and method for a high blood flow extracorporeal circuit |
US11007310B2 (en) | 2018-12-28 | 2021-05-18 | Fresenius Medical Care Holdings, Inc. | Systems and methods for estimating ultrafiltration rates |
WO2022150631A1 (en) * | 2021-01-08 | 2022-07-14 | Hdl Therapeutics, Inc | Systems and methods for reducing low attenuation plaque and/or plaque burden in patients |
WO2023150217A1 (en) * | 2022-02-02 | 2023-08-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Restrictive versus liberal rate of extracorporeal volume removal evaluation in acute kidney injury |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4500309A (en) * | 1982-05-07 | 1985-02-19 | The Kansas University Endowment Association | Method for regional anticoagulation during extracorporeal dialysis |
US5032615A (en) * | 1989-10-31 | 1991-07-16 | The Regents Of The University Of California | Continuous hemodialysis using citrate |
DE4114908A1 (de) * | 1991-05-07 | 1992-11-12 | Klaus Dr Med Sodemann | Dialyseloesung zur dialysebehandlung, konzentrat und vorrichtung zur dialysebehandlung |
JPH115334A (ja) * | 1997-04-23 | 1999-01-12 | Canon Inc | 印刷装置及びその制御方法及び前記印刷装置を接続する情報処理装置及びシステム及び記憶媒体 |
US7670491B2 (en) * | 1998-10-20 | 2010-03-02 | Advanced Renal Technologies | Buffered compositions for dialysis |
US7186420B2 (en) * | 1999-04-26 | 2007-03-06 | Edwards Lifesciences Corporation | Multi-part substitution infusion fluids and matching anticoagulants |
DE60039978D1 (de) * | 1999-04-26 | 2008-10-02 | Edwards Lifesciences Ag | Substitutions-infusionflüssigkeit und zitratanticoagulation |
AU2001274908A1 (en) * | 2000-05-24 | 2001-12-03 | Uab Research Foundation | Use of citrate-containing dialysate for renal dialysis treatment |
EP1347795A2 (en) * | 2000-12-20 | 2003-10-01 | Dialysis Solutions Inc. | Sterile low bicarbonate dialysis concentrate solutions |
DE10114283C2 (de) * | 2000-12-22 | 2003-04-24 | Fresenius Medical Care De Gmbh | Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät |
JP4647953B2 (ja) * | 2003-12-26 | 2011-03-09 | マナック株式会社 | 一剤型重炭酸透析用固形剤及びその製造方法 |
US7544301B2 (en) * | 2004-08-19 | 2009-06-09 | Hhd Llc | Citrate-based dialysate chemical formulations |
-
2005
- 2005-11-14 US US11/273,290 patent/US7884132B2/en active Active
-
2006
- 2006-11-14 PT PT151731395T patent/PT3061456T/pt unknown
- 2006-11-14 EP EP15173139.5A patent/EP3061456B1/en active Active
- 2006-11-14 AU AU2006315455A patent/AU2006315455B2/en active Active
- 2006-11-14 ES ES15173139T patent/ES2832023T3/es active Active
- 2006-11-14 JP JP2008540281A patent/JP2009523117A/ja not_active Withdrawn
- 2006-11-14 PL PL06837587T patent/PL1948205T3/pl unknown
- 2006-11-14 ES ES06837587.2T patent/ES2547607T3/es active Active
- 2006-11-14 DK DK15173139.5T patent/DK3061456T3/da active
- 2006-11-14 DK DK06837587.2T patent/DK1948205T3/en active
- 2006-11-14 CA CA2632157A patent/CA2632157C/en active Active
- 2006-11-14 PT PT68375872T patent/PT1948205E/pt unknown
- 2006-11-14 WO PCT/US2006/044219 patent/WO2007059145A2/en active Application Filing
- 2006-11-14 EP EP06837587.2A patent/EP1948205B1/en active Active
-
2011
- 2011-01-20 US US13/010,770 patent/US8147698B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3061456A3 (en) | 2016-11-30 |
AU2006315455B2 (en) | 2012-07-05 |
AU2006315455A1 (en) | 2007-05-24 |
US7884132B2 (en) | 2011-02-08 |
EP1948205B1 (en) | 2015-06-24 |
EP3061456A2 (en) | 2016-08-31 |
EP1948205A4 (en) | 2010-03-10 |
CA2632157C (en) | 2016-01-12 |
PT1948205E (pt) | 2015-10-16 |
ES2832023T3 (es) | 2021-06-09 |
EP3061456B1 (en) | 2020-07-22 |
CA2632157A1 (en) | 2007-05-24 |
EP1948205A2 (en) | 2008-07-30 |
ES2547607T3 (es) | 2015-10-07 |
US20110230813A1 (en) | 2011-09-22 |
PT3061456T (pt) | 2020-11-20 |
WO2007059145A2 (en) | 2007-05-24 |
JP2009523117A (ja) | 2009-06-18 |
WO2007059145A9 (en) | 2009-07-16 |
US20070110829A1 (en) | 2007-05-17 |
US8147698B2 (en) | 2012-04-03 |
DK3061456T3 (en) | 2022-05-09 |
WO2007059145A3 (en) | 2009-05-07 |
DK1948205T3 (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3061456T3 (en) | Process for metabolic control and high solute clearance and solutions for use therein | |
ZA200710713B (en) | Methods for preventing and treating metabolic disorders and new pyrazole-o-glycoside derivatives | |
GB2434604B (en) | Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same | |
PL2094611T5 (pl) | Sposób i urządzenie do wzbogacania wody pitnej w jony magnezu | |
EP1958033A4 (en) | CONTROL UNIT FOR UTILITY TREATMENT SYSTEMS | |
EP1990727A4 (en) | CACHE CONTROL DEVICE AND CACHE CONTROL PROGRAM | |
EP2016553A4 (en) | APPARATUS FOR MANAGING AND PROCESSING ACCESS | |
IL186386A0 (en) | Active compression screw system and method for using the same | |
EP1863507A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACNE | |
EP1907084A4 (en) | METHOD AND APPARATUS FOR REINVESTIVATING GAINS | |
EP1868101A4 (en) | CACHE STORAGE SYSTEM AND CONTROL PROCEDURE THEREFOR | |
IL188331A0 (en) | Method for the treatment of acne | |
EP1909474A4 (en) | IMAGE PROCESSOR AND METHOD FOR CONTROLLING THE SAME | |
GB0522939D0 (en) | Shared classes cache computer system and method therefor | |
EP1955478A4 (en) | METHOD AND ARRANGEMENT IN AN ACCESS SYSTEM | |
GB2430428B (en) | Device and method for the metering of solutions | |
EP1862906A4 (en) | METHOD AND DEVICE FOR INTERMEDIATE MEMORY CONTROL | |
EP1907468A4 (en) | METHOD FOR PRODUCING NANOVER FIBERS AND NANOVER BASED MATERIALS | |
EP1995265A4 (en) | POLYARYLENE AND PROCESS FOR PRODUCING THE SAME | |
EP1858255A4 (en) | BACKGROUND REPLACEMENT DEVICE, BACKGROUND REPLACEMENT PROGRAM, AND BACKGROUND REPLACEMENT METHOD | |
GB0515138D0 (en) | Acne treatment | |
TWI346671B (en) | Chemical composition and process | |
EP1931209A4 (en) | ANTIMICROBIAL SOLUTIONS AND RELATED METHODS | |
IL185555A0 (en) | Method and composition for treating diabetes | |
TWI371932B (en) | Shared processor architecture and method thereof |